Evidence map›Paper›PMID 30587967›Full record

ArticleInternational journal of nanomedicine2018

Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.

Nour Shobaki, Yusuke Sato, Hideyoshi Harashima

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. High-Throughput Strategies for Streamlining Lipid Nanoparticle Development Pipeline.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Review
  5. Article
  6. Prediction of the Apparent pACS materials Au · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Delivery of gene editing therapeutics.Nanomedicine : nanotechnology, biology, and medicine · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nour ShobakiLaboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan, harasima@pharm.hokudai.ac.jp.
Yusuke SatoLaboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan, harasima@pharm.hokudai.ac.jp.
Hideyoshi HarashimaLaboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan, harasima@pharm.hokudai.ac.jp.
Hokkaido Pharmaceutical University · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe development of targeted drug delivery systems is a rapidly growing area in the field of nanomedicine.

methodsWe report herein on optimizing the targeting efficiency of a lipid nanoparticle (LNP) by manipulating the acid dissociation constant (

resultsThe

conclusionThis strategy has the potential for preparing custom LNPs with endless varieties of structures and final

Indexed as

AnimalsCationsDrug Delivery SystemsEndothelial CellsFluorescenceGene SilencingHepatocytesHydrogen-Ion ConcentrationLipidsLiverMice, Inbred ICRNanoparticlesPiperidinesRNA, Small InterferingCationsLipidsPiperidinesRNA, Small InterferingYSK05acid dissociation constantliver sinusoidal endothelial cellsphysical targetingshort interfering RNA

Identifiers

PMID30587967
PMCPMC6294068
OpenAlexW2904068371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.